Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Device-Directed Therapy for Resistant Hypertension.

Sinan S Tankut1, Ayhan Yoruk1, John D Bisognano1

  • 1University of Rochester Medical Center, 601 Elmwood Avenue, PO Box MED, Rochester, NY 14642, USA.

Cardiology Clinics
|April 17, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Cardiac Resynchronization Therapy on Cardiovascular and Noncardiovascular Hospitalization: A MADIT-CRT Long-Term Follow-Up.

Journal of the American Heart Association·2026
Same author

Flecainide for the Treatment of Andersen-Tawil Syndrome.

JACC. Clinical electrophysiology·2025
Same author

Risk Prediction in Male Adolescents With Congenital Long QT Syndrome: Implications for Sex-Specific Risk Stratification in Potassium Channel-Mediated Long QT Syndrome.

Journal of the American Heart Association·2024
Same author

Treating Hypertension in Patients With Orthostatic Hypotension: Benefits vs Harms in the Era of Aggressive Blood Pressure Lowering.

JAMA·2023
Same author

Team-based home blood pressure monitoring for blood pressure equity a protocol for a stepped wedge cluster randomized trial.

Contemporary clinical trials·2023
Same author

Insertable cardiac monitor-guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol (ICM-REDUCE-AF trial).

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2023
Same journal

At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

Cardiology clinics·2026
Same journal

End-of-Life Care in the Cardiovascular Intensive Care Unit.

Cardiology clinics·2026
Same journal

Strategies to Reduce Failure to Rescue after Cardiac Surgery.

Cardiology clinics·2026
Same journal

Embracing Enhanced Recovery After Cardiac Surgery Program.

Cardiology clinics·2026
Same journal

Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

Cardiology clinics·2026
Same journal

A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

Cardiology clinics·2026
See all related articles

Resistant hypertension poses significant health risks. Innovative interventions like renal denervation, median nerve stimulation, and baroreceptor activation therapy are being explored for patients unresponsive to standard treatments.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Neurology

Background:

  • Hypertension is a major global health concern and a leading risk factor for cardiovascular and renal diseases.
  • Resistant hypertension, defined as blood pressure that remains high despite the use of three or more antihypertensive medications, is associated with increased morbidity and mortality.
  • Despite pharmacotherapy advancements, a subset of patients with resistant hypertension requires novel therapeutic strategies.

Purpose of the Study:

  • To review current evidence on innovative interventions for resistant hypertension.
  • To summarize findings from clinical trials investigating renal denervation, median nerve stimulation, and baroreceptor activation therapy.
  • To provide an overview of emerging treatment options for patients with refractory hypertension.
Keywords:
Baroreceptor activation therapyMedian nerve stimulationRenal denervationResistant hypertension

Related Experiment Videos

Main Methods:

  • Systematic review of existing literature and clinical trial data.
  • Analysis of studies evaluating the efficacy and safety of renal denervation.
  • Evaluation of research on median nerve stimulation and baroreceptor activation therapy.

Main Results:

  • Evidence suggests potential benefits of renal denervation in reducing blood pressure in select patients.
  • Preliminary data on median nerve stimulation indicate its feasibility and potential for blood pressure reduction.
  • Baroreceptor activation therapy has shown promise in clinical trials for lowering blood pressure in resistant cases.

Conclusions:

  • Innovative interventions offer new hope for managing resistant hypertension.
  • Further research and larger clinical trials are needed to establish the long-term efficacy and safety of these novel therapies.
  • These approaches represent a paradigm shift in treating complex hypertension cases.